Depression but not non-persistence to antidiabetic drugs is associated with mortality in type 2 diabetes

被引：0
|
作者：
Lunghi, Carlotta [1 ,2 ]
Zongo, Arsene [2 ,3 ]
Tardif, Isabelle [4 ]
Demers, Eric [2 ]
Diendere, Joel D. R. [2 ,3 ]
Guenette, Line [2 ,3 ]
机构：
[1] Univ Quebec, Dept Hlth Sci, Rimouski, PQ, Canada
[2] CHU Quebec, Ctr Rech, Axe Sante Populat & Prat Optim Sante SPPOS, Quebec City, PQ, Canada
[3] Univ Laval, Fac Pharm, Quebec City, PQ, Canada
[4] Univ Laval, Fac Med, Quebec City, PQ, Canada
来源：
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY | 2021年 / 43卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
ESPACOMP-2
引用
收藏
页码：299 / 300
页数：2
相关论文
共 50 条
  • [1] Depression but not non-persistence to antidiabetic drugs is associated with mortality in type 2 diabetes: A nested case-control study
    Lunghi, Carlotta
    Zongo, Arsene
    Tardif, Isabelle
    Demers, Eric
    Diendere, Joel Desire Relwende
    Guenette, Line
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2021, 171
  • [2] Depression and the risk of hospitalization in type 2 diabetes patients: A nested case-control study accounting for non-persistence to antidiabetic treatment
    Tardif, Isabelle
    Guenette, Line
    Zongo, Arsene
    Demers, Eric
    Lunghi, Carlotta
    DIABETES & METABOLISM, 2022, 48 (04)
  • [3] Non-Persistence of GLP-1 Analogues in Type 2 Diabetes in France
    Roussel, Ronan
    Charbonnel, Bernard
    Behar, Mourad
    Gourmelen, Julie
    Emery, Corinne
    Detournay, Bruno
    DIABETES, 2017, 66 : A301 - A302
  • [4] Milk intake, lactase non-persistence and type 2 diabetes risk in Chinese adults
    Kakkoura, Maria G.
    Walters, Robin G.
    Clarke, Robert
    Chen, Zhengming
    Du, Huaidong
    NATURE METABOLISM, 2024, 6 (11) : 2054 - 2056
  • [5] Reply to: Milk intake, lactase non-persistence and type 2 diabetes risk in Chinese adults
    Luo, Kai
    Zhang, Yanbo
    Kaplan, Robert C.
    Qi, Qibin
    NATURE METABOLISM, 2024, 6 (11) : 2057 - 2059
  • [6] GLP-1 NON-PERSISTENCE: A SURVEY OF ADULTS WITH TYPE 2 DIABETES IN THE UK AND USA
    Pfeiffer, K. M.
    Basse, A.
    Lee, X. Y.
    Brod, M.
    VALUE IN HEALTH, 2018, 21 : S76 - S76
  • [7] Pharmacogenomics in type 2 diabetes: oral antidiabetic drugs
    Daniels, M. A.
    Kan, C.
    Willmes, D. M.
    Ismail, K.
    Pistrosch, F.
    Hopkins, D.
    Mingrone, G.
    Bornstein, S. R.
    Birkenfeld, A. L.
    PHARMACOGENOMICS JOURNAL, 2016, 16 (05): : 399 - 410
  • [8] Pharmacogenomics in type 2 diabetes: oral antidiabetic drugs
    M A Daniels
    C Kan
    D M Willmes
    K Ismail
    F Pistrosch
    D Hopkins
    G Mingrone
    S R Bornstein
    A L Birkenfeld
    The Pharmacogenomics Journal, 2016, 16 : 399 - 410
  • [9] Antidiabetic drugs and cognitive impairment in type 2 diabetes
    Matveeva, Mariia, V
    Samoilova, Yulia G.
    Zhukova, Natalia G.
    Oleynik, Oxana A.
    Rotkank, Mariya A.
    Leiman, Olga P.
    Kudlay, Dmitry A.
    MEDICAL SCIENCE, 2019, 23 (97) : 369 - 374
  • [10] DETERMINANTS OF NON-PERSISTENCE TO ANTIOSTEOPOROTIC DRUGS BY USING ADMINISTRATIVE DATABASE
    Orlando, V
    Guerriero, F.
    Monetti, V. M.
    Putignano, D.
    Moretti, A.
    Iolascon, G.
    Menditto, E.
    VALUE IN HEALTH, 2014, 17 (07) : A384 - A384
12345